Clinical trial
OnCovid: Natural History and Outcomes of Cancer Patients During the COVID19 Epidemic
NCT04393974 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OnCovid: Natural History and Outcomes of Cancer Patients During the COVID19 Epidemic
- Lead sponsor
- Imperial College London
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2020
- Completion date
- April 1, 2024
- Enrollment
- 3,820 (actual)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, sars-cov2